Drug and Gene Delivery Devices Market (By Delivery Type: Oral, Ocular, Inhalation, Nasal, Injectable, Transdermal, and Topical; By Method: In Situ and Ex Vivo; By Vector: Viral and Non-Viral)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

The global Drug and Gene Delivery Devices market size was estimated at USD 411 billion in 2021 and is expected to surpass around USD 820 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 7.9% during the forecast period 2022 to 2030.

Growing efforts towards formulating dosage forms that would help in maximizing the bioavailability of the drug at the target site while increasing patient convenience are driving the global market growth. The introduction of novel drug delivery systems such as subdermal implants that are available in different forms such as rings and patches are expected to aid in the industry growth.

The evolution of the drug delivery systems is directly attributed to changing preferences by patients as well as healthcare professionals. A few of the many advancements include-

     • Introduction of Biopharmaceutical classification systems (BCS) class II drug in oral dosage forms

     • Introduction of auto-injectors

     • Availability of advanced implants in customized shapes and sizes

     • Introduction of advanced pulmonary devices such as Smartcard and Adaptive Aerosol Delivery

Report Scope of the Drug and Gene Delivery Devices Market

Report Coverage

Details

Market Size

US$ 820 Billion by 2030

Growth Rate

CAGR of 7.9% from 2022 to 2030

Largest Market

North America

Fastest Growing Market

Asia Pacific

Base Year

2021

Forecast Period

2022 to 2030

Segments Covered

Delivery Type, Method, Vector and Region,

Companies Mentioned

 Pfizer, Inc., F. Hoffmann-La Roche Ltd, Johnson and Johnson Private Ltd, Novartis AG, Bayer AG, Becton, Dickinson and Company, Uniqure NV

Drug And Gene Delivery Devices Market Trends

The global market for drug and gene delivery devices has expanded with the increased prevalence of numerous chronic diseases, such as cancer, diabetes, cardiovascular diseases, and other technological developments in drug delivery. Additionally, the demand for drug and gene delivery devices has grown with the patients' and physicians' changing preferences, driving the market's expansion.

The market for drug and gene delivery devices is anticipated to rise owing to the increasing need for injectable medications. The global market for drug and gene delivery devices has expanded with the increased prevalence of numerous chronic diseases like cancer, diabetes, cardiovascular diseases, and other technological developments in drug delivery. Additionally, the major players in the field of genomics are increasing their efforts in research and development. The demand for drug and gene delivery devices has grown with the patients' and physicians' changing preferences, driving the market's expansion.

The market for drug and gene delivery devices is anticipated to rise owing to the increasing need for injectable medications. Players in the injectable medicine market are getting regulatory approval for various treatments used in syringes to increase their market share over the forecast period.

The market for drug delivery devices is anticipated to hinder due to regulatory approvals uncertainties. Investments in new product innovations are pushed to the limit due to the possibility of revenue loss from delays in product releases and increased costs paid due to strict regulatory processes, which is impacting the expansion of the drug and gene delivery devices market.

Technological developments in injectable medical equipment have accelerated patient acceptance of self-injectable devices. Since the diabetic patient has to inject insulin regularly, the growing diabetic population is driving the expansion of this market. The rise in popularity of self-injectors, pen-injectors, needle-free injectors, and auto-injectors has made it possible for patients to administer medications at home without needing medical help. The drug and gene delivery device market is anticipated to be significantly impacted by all of these factors, which is expected to increase demand for injectable products over the forecast period.

Delivery Type Insights

Based on delivery type, the oral segment dominated the global drug and gene delivery devices market in 2020, in terms of revenue and is estimated to sustain its dominance during the forecast period. The oral drug delivery is the most convenient and most popular route of administration all over the globe. It is economical, pain-free, and self-administered type of delivery where no sterile precautions are involved. Moreover, the development of various therapeutics that can identify the affected cell and can treat that cell without harming the normal cells is exponentially boosting the growth of this segment. Therefore, the rapid growth of the biosimilar, targeted therapeutics, and gene therapies had positively impacted the market growth in the past few years.

On the other hand, the injectable is estimated to be the most opportunistic segment during the forecast period. The technological advancements in the injectable devices has propelled the adoption of the self-injectable devices among the patients. The rising number of diabetic population is fostering the growth of this segment as the diabetic patient need to regularly inject insulin. 

Methods Insights

Based on the method used, gene delivery system is segmented as in situ and ex vivo. Most of the currently approved drugs act by in situ methods. Thus, the in situ segment is currently dominating the industry with the largest share.

High focus on the in situ methods owing to its ease of performance is expected to make it the fastest growing segment in the space. However, the segment growth is expected to impede the low efficiency of transduction procedures.

Vector Insights

Viral vectors currently dominate the gene delivery systems market with 4 approved drugs. More than 60% of the ongoing clinical trials on gene therapies are based on the viral vectors for transfection. Thus, the viral segment is expected to remain dominant throughout the forecast period.

Viral vectors enable complex procedures involved in transfection procedures such as gene gun, magnetofection, ultrasound, and hydrodynamic. In addition, it has increased the success rate of the gene transfer as compared to its counterpart techniques.

Region Insights

Based on region, North America dominated the global drug and gene delivery devices market in 2020, in terms of revenue and is estimated to sustain its dominance during the forecast period. This is attributed to the increased number of people suffering from various chronic diseases. According to a study, around 60% of the US population is suffering from at least one chronic diseases. Moreover, the development of various therapeutics and innovative drugs that can effectively treat chronic diseases and genetic diseases is fueling the demand for the drug and gene delivery devices market. Moreover, the rising popularity of personalized medicines may impact the market positively in the forthcoming years.

Asia Pacific is estimated to be the most opportunistic market during the forecast period. This is attributed to the rising prevalence of various chronic and infectious diseases, rapidly growing biopharmaceutical industry, presence of huge population, and rising prevalence of diseases caused by pollution owing to the rapid industrialization and urbanization.

Some of the prominent players in the Drug and Gene Delivery Devices Market include:

  • Pfizer, Inc.
  • F. Hoffmann-La Roche Ltd
  • Johnson and Johnson Private Ltd
  • Novartis AG
  • Bayer AG
  • Becton, Dickinson and Company
  • Uniqure NV

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Drug and Gene Delivery Devices market

By Delivery Type

  • Oral
  • Ocular
  • Inhalation
  • Nasal
  • Injectable
  • Transdermal
  • Topical

By Method

  • In Situ
  • Ex Vivo

By Vector

  • Viral Vector
  • Non-Viral Vector

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Key Points Covered in Drug and Gene Delivery Devices Market Study:

  • Growth of Drug and Gene Delivery Devices in 2022
  • Market Estimates and Forecasts (2017-2030)
  •  Brand Share and Market Share Analysis
  •  Key Drivers and Restraints Shaping Market Growth
  •  Segment-wise, Country-wise, and Region-wise Analysis
  •  Competition Mapping and Benchmarking
  •  Recommendation on Key Winning Strategies
  •  COVID-19 Impact on Demand for Drug and Gene Delivery Devices and How to Navigate
  •  Key Product Innovations and Regulatory Climate
  •  Drug and Gene Delivery Devices Consumption Analysis
  •  Drug and Gene Delivery Devices Production Analysis
  •  Drug and Gene Delivery Devices and Management